The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients

Abstract Objective Although the tumor mutation burden (TMB) was reported as a biomarker for immunotherapy of various cancers, whether it can effectively predict the survival prognosis in breast cancer patients remains unclear. In this study, the prognostic value of TMB and its correlation with immun...

Full description

Bibliographic Details
Main Authors: Shengjin Cui, Jingying Feng, Xi Tang, Shuang Lou, Weiquan Guo, Xiaowei Xiao, Shuping Li, Xue Chen, Yu Huan, Yiwen Zhou, Lijia Xiao
Format: Article
Language:English
Published: BMC 2023-02-01
Series:European Journal of Medical Research
Subjects:
Breast cancer
Tumor mutation burden (TMB)
Immune infiltrate
Survival
Online Access:https://doi.org/10.1186/s40001-023-01058-x

Internet

https://doi.org/10.1186/s40001-023-01058-x

Similar Items